160 related articles for article (PubMed ID: 26567591)
1. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
[TBL] [Abstract][Full Text] [Related]
2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
3. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
[TBL] [Abstract][Full Text] [Related]
4. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
[TBL] [Abstract][Full Text] [Related]
6. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
7. Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration.
Ramirez G; Pham AC; Clulow AJ; Salim M; Hawley A; Boyd BJ
Drug Deliv Transl Res; 2021 Jun; 11(3):1236-1244. PubMed ID: 32935235
[TBL] [Abstract][Full Text] [Related]
8. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
Kossena GA; Charman WN; Boyd BJ; Porter CJ
J Control Release; 2004 Sep; 99(2):217-29. PubMed ID: 15380632
[TBL] [Abstract][Full Text] [Related]
9. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
[TBL] [Abstract][Full Text] [Related]
10. Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent.
Qin L; Mei L; Shan Z; Huang Y; Pan X; Li G; Gu Y; Wu C
Drug Dev Ind Pharm; 2016; 42(2):307-16. PubMed ID: 26035332
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.
Hong L; Salentinig S; Hawley A; Boyd BJ
Langmuir; 2015 Jun; 31(24):6933-41. PubMed ID: 26029994
[TBL] [Abstract][Full Text] [Related]
12. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
Lee KW; Nguyen TH; Hanley T; Boyd BJ
Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
[TBL] [Abstract][Full Text] [Related]
13. Drug release from lipid liquid crystalline phases: relation with phase behavior.
Costa-Balogh FO; Sparr E; Sousa JJ; Pais AC
Drug Dev Ind Pharm; 2010 Apr; 36(4):470-81. PubMed ID: 19848561
[TBL] [Abstract][Full Text] [Related]
14. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
15. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
Kossena GA; Charman WN; Boyd BJ; Porter CJ
J Pharm Sci; 2005 Mar; 94(3):481-92. PubMed ID: 15619248
[TBL] [Abstract][Full Text] [Related]
16. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
[TBL] [Abstract][Full Text] [Related]
17. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
Bisset NB; Boyd BJ; Dong YD
Int J Pharm; 2015 Nov; 495(1):241-248. PubMed ID: 26319637
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
Drug Deliv Transl Res; 2011 Dec; 1(6):429-38. PubMed ID: 25786363
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
20. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
